Literature DB >> 10873722

Haemostasis in patients with Behçet's disease.

S Demirer1, N Sengül, M A Yerdel, A Tüzüner, A T Ulus, A Gürler, D Bergqvist, A Siegbahn, S Karacagil.   

Abstract

AIM: to determine whether Behçet's disease affects haemostatic function.
SETTING: University Hospital, Turkey. PATIENTS: one hundred and twenty-seven consecutive patients with Behçet's disease, 34 of whom with a history of vascular involvement.
METHODS: prothrombin fragment 1+2 tissue plasminogen activator, protein S and C, antithrombin, fibrinogen, von Willebrand factor, thrombomodulin and prothrombin time (PT) were measured in patient plasma.
RESULTS: soluble thrombomodulin was significantly lower and von Willebrand factor (vWF) and tissue plasminogen activator (tPA) significantly higher in Behçet's patients. Patients with vascular involvement showed the highest levels of vWF and tPA. There was no activation of coagulation, not even in patients with an active disease at the time of sampling.
CONCLUSION: there were indirect signs of endothelial activity or damage, particularly in patients with vascular involvement. Coagulation was not activated. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873722     DOI: 10.1053/ejvs.2000.1091

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  8 in total

Review 1.  Behçet's disease and thrombophilia.

Authors:  M Leiba; Y Sidi; H Gur; A Leiba; M Ehrenfeld
Journal:  Ann Rheum Dis       Date:  2001-12       Impact factor: 19.103

2.  Decreased protein S activity is related to the disease activity of Behcet's disease.

Authors:  Seong Ryul Kwon; Mie Jin Lim; Shin Goo Park; Yeon Sook Moon; Won Park
Journal:  Rheumatol Int       Date:  2006-09-13       Impact factor: 2.631

3.  Identification of possible pathogenic pathways in Behçet's disease using genome-wide association study data from two different populations.

Authors:  Burcu Bakir-Gungor; Elaine F Remmers; Akira Meguro; Nobuhisa Mizuki; Daniel L Kastner; Ahmet Gul; Osman U Sezerman
Journal:  Eur J Hum Genet       Date:  2014-09-17       Impact factor: 4.246

4.  Haemostatic Parameters in Patients with Behçet's Disease.

Authors:  Juma K Alkaabi; David Gravell; Hamood Al-Haddabi; Anil Pathare
Journal:  Sultan Qaboos Univ Med J       Date:  2014-04-07

5.  Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease.

Authors:  Fuat Erdem; Mehmet Gündoğdu; Ilhami Kiki; Refik Ali Sari; Ahmet Kiziltunç
Journal:  Rheumatol Int       Date:  2004-07-15       Impact factor: 2.631

6.  Behçet's Disease as a Model of Venous Thrombosis.

Authors:  Micaela La Regina; Armen Yuri Gasparyan; Francesco Orlandini; Domenico Prisco
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

7.  Behcet's Disease: New Concepts in Cardiovascular Involvements and Future Direction for Treatment.

Authors:  M B Owlia; G Mehrpoor
Journal:  ISRN Pharmacol       Date:  2012-03-08

8.  Behçet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity.

Authors:  Ihosvany Fernández-Bello; Francisco J López-Longo; Elena G Arias-Salgado; Víctor Jiménez-Yuste; Nora V Butta
Journal:  Orphanet J Rare Dis       Date:  2013-05-27       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.